Sipp Industries（SIPC）株式概要コングロマリット企業であるシップ・インダストリーズ社（OTCPK:SIPC）は、技術、輸出入、商業・消費者向け製品の流通に従事している。 詳細SIPC ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析意味のある時価総額がありません ( $405K )最新の財務報告は1年以上前のものである US市場と比較して、過去 3 か月間の株価の変動が非常に大きいすべてのリスクチェックを見るSIPC Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.00099該当なし内在価値ディスカウントEst. Revenue$PastFuture-2k12016201920222025202620282031Revenue US$1.0Earnings US$0.09AdvancedSet Fair ValueView all narrativesSipp Industries, Inc. 競合他社Linkers IndustriesSymbol: NasdaqCM:LNKSMarket cap: US$90.3kErayak Power Solution GroupSymbol: NasdaqCM:RAYAMarket cap: US$3.1mSUNation EnergySymbol: NasdaqCM:SUNEMarket cap: US$4.2mExpion360Symbol: NasdaqCM:XPONMarket cap: US$5.7m価格と性能株価の高値、安値、推移の概要Sipp Industries過去の株価現在の株価US$0.0009952週高値US$0.001752週安値US$0.00075ベータ01ヶ月の変化16.82%3ヶ月変化-3.12%1年変化-29.07%3年間の変化-44.83%5年間の変化-88.97%IPOからの変化-99.90%最新ニュースお知らせ • Jun 25Sipp Industries, Inc. Announces Chief Executive Officer ChangesSIPP Industries, Inc. announced the appointment of Adam Graziano as the new Chief Executive Officer, effective immediately. Jakob Jorgensen, the former CEO of SIPP Industries, will remain a business consultant while also joining Calypso Pharmaceuticals as their new CEO. Mr. Jorgensen's new role will focus on advancing the recent research and development agreement between Calypso Pharmaceuticals and SIPP Industries. This collaboration aims to develop a groundbreaking topical treatment utilizing Peptide P16, designed to penetrate and destroy melanoma cells. Additionally, the partnership will explore the potential of other peptides in combating obesity, anxiety, Alzheimer’s disease, and various other conditions. Adam Graziano brings a wealth of experience and leadership to SIPP Industries. With 20 years in various business leadership roles and over 33 years in the insurance sector, while currently managing a $500 million portfolio, Mr. Graziano has consistently demonstrated his ability to guide teams in achieving and surpassing growth and financial objectives. He holds a Bachelor of Arts in Political Science with a minor in Criminal Justice from St. Cloud State University.お知らせ • Jun 16Sipp Industries Announces Newly Released Delta-8 Sauces, Tea, Fruit Punch and Medicinal Pain LotionSipp Industries, Inc. announced that it has developed and manufactured a new line of Delta-8 (“D8”) infused sauces under the “Sauz” brand. The Company recently completed its first production run of Major Hemp D8 Sweet Lemon Tea and Fruit Punch which will be placed in retail coolers throughout the south-central states with national distribution plans underway at additional distributors. Sipp Industries also reports it officially fulfilled its first orders for the newly developed THC-infused pain lotion under the Aveina brand. With Aveina being the first THC product launch it will exclusively be sold in dispensaries throughout the state of Oklahoma. In April, Sipp Industries began the development and manufacturing process for its new line of Sauz D8 infused sauces. Inspired from an inquiry with a large prospect, Sipp Industries developed a variety of D8 nano-infused sauce flavors including BBQ, Chipotle, Siracha, Buffalo and Steak. These new 10oz sauces pack a powerful punch with 1,000mg of nano emulsified D8 providing an uplifting and euphoric eating experience with your favorite foods. Sipp Industries is planning sampling events at BBQ competitions/cook-offs and other “canna-competitions” for edibles and beverages throughout the summer. The Company is also pursuing brand ambassadors to penetrate the cannabis-infused cuisine market which has become extremely popular for celebrity chefs on Netflix shows such as Bong Appetite and Cooking on High.お知らせ • May 06Sipp Industries Introduces New THC Nano-Infused Medicinal Body LotionSipp Industries, Inc. received an order for its newly developed THC Nano-Infused Body Lotion which will be branded and marketed under the Aveina brand. Over the past several weeks, Sipp Industries formulated and developed its first THC product which is a medicinal grade body lotion used for pain relief, anti-inflammatory, anti-aging, and anti-cancer applications. Aveina is expected to be on the shelves by the end of the month at legally operated medical marijuana dispensaries throughout the state of Oklahoma. Sipp Industries has partnered with its exclusive distributor, Argent Cannabis. Aveina will be sold in 4 oz sizes containing a potent 500mg of Nano THC. With 95% THC bioavailability, Aveina provides fast acting, effective pain relief.お知らせ • Feb 04Sipp Industries Announces First Product Launch of 2022Sipp Industries, Inc. announced the launch of its first product of the year, Nano CBN Drops, addressing the growing cannabis sleep aid market. Sipp Industries has finalized its formula with the primary ingredient being high-grade nano emulsified CBN (cannabidiol). Similar to CBD, the benefits of CBN include anti-inflammatory, pain relief and enhanced sleep quality. These drops will be in 100mg and 200mg dosages which can be added sublingually or in any choice of beverage. The CBN drops are completely water-soluble that contribute to the increasing bioavailability and effects. Approximately 30% to 48% of older adults suffer from insomnia. The cumulative long-term effects of sleep disorders have been found to cause increased risks of depression, hypertension, obesity, diabetes, heart attack, and stroke. Sipp Industries plans to market Nano Drops worldwide through both online sales and traditional distribution channels.お知らせ • Jan 05Sipp Industries, Inc. (OTCPK:SIPC) acquired 5% stake in Calypso Extracts.Sipp Industries, Inc. (OTCPK:SIPC) acquired 5% stake in Calypso Extracts on January 4, 2022. Under the terms of the agreement, Sipp Industries had acquired a 5% stake in Calypso, with an option to acquire up to 10% within 12 months. Sipp Industries, Inc. (OTCPK:SIPC) completed the acquisition of 5% stake in Calypso Extracts on January 4, 2022.お知らせ • Aug 21Sipp Industries, Inc. Announces Appointment of Nick Pelletiere as Acting Chief Executive OfficerSipp Industries, Inc. announced appointment of Nick Pelletiere as its new Acting Chief Executive Officer. Mr. Pelletiere offers a history of profitable business ventures. He has a proven track record in driving the rapid growth and development of small and medium-sized businesses, as well as large corporations, resulting in significant increases in revenue and market share. He offers dynamic and results-driven sales with 25+ years of sales experience across various industries, marketing, and management experience as well as ownership in business partnerships. Mr. Pelletiere has a very entrepreneurial, enthusiastic, and passionate mindset to generate leads, pursue and secure new business opportunities, as well as meet and exceed sales targets.最新情報をもっと見るRecent updatesお知らせ • Jun 25Sipp Industries, Inc. Announces Chief Executive Officer ChangesSIPP Industries, Inc. announced the appointment of Adam Graziano as the new Chief Executive Officer, effective immediately. Jakob Jorgensen, the former CEO of SIPP Industries, will remain a business consultant while also joining Calypso Pharmaceuticals as their new CEO. Mr. Jorgensen's new role will focus on advancing the recent research and development agreement between Calypso Pharmaceuticals and SIPP Industries. This collaboration aims to develop a groundbreaking topical treatment utilizing Peptide P16, designed to penetrate and destroy melanoma cells. Additionally, the partnership will explore the potential of other peptides in combating obesity, anxiety, Alzheimer’s disease, and various other conditions. Adam Graziano brings a wealth of experience and leadership to SIPP Industries. With 20 years in various business leadership roles and over 33 years in the insurance sector, while currently managing a $500 million portfolio, Mr. Graziano has consistently demonstrated his ability to guide teams in achieving and surpassing growth and financial objectives. He holds a Bachelor of Arts in Political Science with a minor in Criminal Justice from St. Cloud State University.お知らせ • Jun 16Sipp Industries Announces Newly Released Delta-8 Sauces, Tea, Fruit Punch and Medicinal Pain LotionSipp Industries, Inc. announced that it has developed and manufactured a new line of Delta-8 (“D8”) infused sauces under the “Sauz” brand. The Company recently completed its first production run of Major Hemp D8 Sweet Lemon Tea and Fruit Punch which will be placed in retail coolers throughout the south-central states with national distribution plans underway at additional distributors. Sipp Industries also reports it officially fulfilled its first orders for the newly developed THC-infused pain lotion under the Aveina brand. With Aveina being the first THC product launch it will exclusively be sold in dispensaries throughout the state of Oklahoma. In April, Sipp Industries began the development and manufacturing process for its new line of Sauz D8 infused sauces. Inspired from an inquiry with a large prospect, Sipp Industries developed a variety of D8 nano-infused sauce flavors including BBQ, Chipotle, Siracha, Buffalo and Steak. These new 10oz sauces pack a powerful punch with 1,000mg of nano emulsified D8 providing an uplifting and euphoric eating experience with your favorite foods. Sipp Industries is planning sampling events at BBQ competitions/cook-offs and other “canna-competitions” for edibles and beverages throughout the summer. The Company is also pursuing brand ambassadors to penetrate the cannabis-infused cuisine market which has become extremely popular for celebrity chefs on Netflix shows such as Bong Appetite and Cooking on High.お知らせ • May 06Sipp Industries Introduces New THC Nano-Infused Medicinal Body LotionSipp Industries, Inc. received an order for its newly developed THC Nano-Infused Body Lotion which will be branded and marketed under the Aveina brand. Over the past several weeks, Sipp Industries formulated and developed its first THC product which is a medicinal grade body lotion used for pain relief, anti-inflammatory, anti-aging, and anti-cancer applications. Aveina is expected to be on the shelves by the end of the month at legally operated medical marijuana dispensaries throughout the state of Oklahoma. Sipp Industries has partnered with its exclusive distributor, Argent Cannabis. Aveina will be sold in 4 oz sizes containing a potent 500mg of Nano THC. With 95% THC bioavailability, Aveina provides fast acting, effective pain relief.お知らせ • Feb 04Sipp Industries Announces First Product Launch of 2022Sipp Industries, Inc. announced the launch of its first product of the year, Nano CBN Drops, addressing the growing cannabis sleep aid market. Sipp Industries has finalized its formula with the primary ingredient being high-grade nano emulsified CBN (cannabidiol). Similar to CBD, the benefits of CBN include anti-inflammatory, pain relief and enhanced sleep quality. These drops will be in 100mg and 200mg dosages which can be added sublingually or in any choice of beverage. The CBN drops are completely water-soluble that contribute to the increasing bioavailability and effects. Approximately 30% to 48% of older adults suffer from insomnia. The cumulative long-term effects of sleep disorders have been found to cause increased risks of depression, hypertension, obesity, diabetes, heart attack, and stroke. Sipp Industries plans to market Nano Drops worldwide through both online sales and traditional distribution channels.お知らせ • Jan 05Sipp Industries, Inc. (OTCPK:SIPC) acquired 5% stake in Calypso Extracts.Sipp Industries, Inc. (OTCPK:SIPC) acquired 5% stake in Calypso Extracts on January 4, 2022. Under the terms of the agreement, Sipp Industries had acquired a 5% stake in Calypso, with an option to acquire up to 10% within 12 months. Sipp Industries, Inc. (OTCPK:SIPC) completed the acquisition of 5% stake in Calypso Extracts on January 4, 2022.お知らせ • Aug 21Sipp Industries, Inc. Announces Appointment of Nick Pelletiere as Acting Chief Executive OfficerSipp Industries, Inc. announced appointment of Nick Pelletiere as its new Acting Chief Executive Officer. Mr. Pelletiere offers a history of profitable business ventures. He has a proven track record in driving the rapid growth and development of small and medium-sized businesses, as well as large corporations, resulting in significant increases in revenue and market share. He offers dynamic and results-driven sales with 25+ years of sales experience across various industries, marketing, and management experience as well as ownership in business partnerships. Mr. Pelletiere has a very entrepreneurial, enthusiastic, and passionate mindset to generate leads, pursue and secure new business opportunities, as well as meet and exceed sales targets.株主還元SIPCUS ElectricalUS 市場7D10.3%-1.4%1.0%1Y-29.1%87.3%28.7%株主還元を見る業界別リターン: SIPC過去 1 年間で87.3 % の収益を上げたUS Electrical業界を下回りました。リターン対市場: SIPCは、過去 1 年間で28.7 % のリターンを上げたUS市場を下回りました。価格変動Is SIPC's price volatile compared to industry and market?SIPC volatilitySIPC Average Weekly Movement31.6%Electrical Industry Average Movement12.9%Market Average Movement7.2%10% most volatile stocks in US Market16.4%10% least volatile stocks in US Market3.1%安定した株価: SIPCの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: SIPCの weekly volatility ( 32% ) は過去 1 年間安定していますが、依然としてUSの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1993n/aAdam Grazianowww.sippindustries.comシップ・インダストリーズ社(OTCPK:SIPC)は、コングロマリット企業で、技術、輸出入、商業・消費者向け製品の流通に従事している。主に屋内園芸用途の先進プラズマ照明ソリューションの製品ラインを提供している。シップ・インダストリーズ社の前身はプロマックス・コミュニケーション社で、2007年4月に社名をシップ・インダストリーズ社に変更した。同社は1993年に設立され、カリフォルニア州コスタメサに本社を置き、コロラド州ランチにも事務所を構えている。もっと見るSipp Industries, Inc. 基礎のまとめSipp Industries の収益と売上を時価総額と比較するとどうか。SIPC 基礎統計学時価総額US$405.43k収益（TTM）-US$2.50k売上高(TTM)n/a0.0xP/Sレシオ0.0xPER（株価収益率SIPC は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計SIPC 損益計算書（TTM）収益US$0売上原価US$0売上総利益US$0その他の費用US$2.50k収益-US$2.50k直近の収益報告Dec 31, 2011次回決算日該当なし一株当たり利益（EPS）0グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率0.0%SIPC の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 08:10終値2026/05/22 00:00収益2011/12/31年間収益2011/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sipp Industries, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 25Sipp Industries, Inc. Announces Chief Executive Officer ChangesSIPP Industries, Inc. announced the appointment of Adam Graziano as the new Chief Executive Officer, effective immediately. Jakob Jorgensen, the former CEO of SIPP Industries, will remain a business consultant while also joining Calypso Pharmaceuticals as their new CEO. Mr. Jorgensen's new role will focus on advancing the recent research and development agreement between Calypso Pharmaceuticals and SIPP Industries. This collaboration aims to develop a groundbreaking topical treatment utilizing Peptide P16, designed to penetrate and destroy melanoma cells. Additionally, the partnership will explore the potential of other peptides in combating obesity, anxiety, Alzheimer’s disease, and various other conditions. Adam Graziano brings a wealth of experience and leadership to SIPP Industries. With 20 years in various business leadership roles and over 33 years in the insurance sector, while currently managing a $500 million portfolio, Mr. Graziano has consistently demonstrated his ability to guide teams in achieving and surpassing growth and financial objectives. He holds a Bachelor of Arts in Political Science with a minor in Criminal Justice from St. Cloud State University.
お知らせ • Jun 16Sipp Industries Announces Newly Released Delta-8 Sauces, Tea, Fruit Punch and Medicinal Pain LotionSipp Industries, Inc. announced that it has developed and manufactured a new line of Delta-8 (“D8”) infused sauces under the “Sauz” brand. The Company recently completed its first production run of Major Hemp D8 Sweet Lemon Tea and Fruit Punch which will be placed in retail coolers throughout the south-central states with national distribution plans underway at additional distributors. Sipp Industries also reports it officially fulfilled its first orders for the newly developed THC-infused pain lotion under the Aveina brand. With Aveina being the first THC product launch it will exclusively be sold in dispensaries throughout the state of Oklahoma. In April, Sipp Industries began the development and manufacturing process for its new line of Sauz D8 infused sauces. Inspired from an inquiry with a large prospect, Sipp Industries developed a variety of D8 nano-infused sauce flavors including BBQ, Chipotle, Siracha, Buffalo and Steak. These new 10oz sauces pack a powerful punch with 1,000mg of nano emulsified D8 providing an uplifting and euphoric eating experience with your favorite foods. Sipp Industries is planning sampling events at BBQ competitions/cook-offs and other “canna-competitions” for edibles and beverages throughout the summer. The Company is also pursuing brand ambassadors to penetrate the cannabis-infused cuisine market which has become extremely popular for celebrity chefs on Netflix shows such as Bong Appetite and Cooking on High.
お知らせ • May 06Sipp Industries Introduces New THC Nano-Infused Medicinal Body LotionSipp Industries, Inc. received an order for its newly developed THC Nano-Infused Body Lotion which will be branded and marketed under the Aveina brand. Over the past several weeks, Sipp Industries formulated and developed its first THC product which is a medicinal grade body lotion used for pain relief, anti-inflammatory, anti-aging, and anti-cancer applications. Aveina is expected to be on the shelves by the end of the month at legally operated medical marijuana dispensaries throughout the state of Oklahoma. Sipp Industries has partnered with its exclusive distributor, Argent Cannabis. Aveina will be sold in 4 oz sizes containing a potent 500mg of Nano THC. With 95% THC bioavailability, Aveina provides fast acting, effective pain relief.
お知らせ • Feb 04Sipp Industries Announces First Product Launch of 2022Sipp Industries, Inc. announced the launch of its first product of the year, Nano CBN Drops, addressing the growing cannabis sleep aid market. Sipp Industries has finalized its formula with the primary ingredient being high-grade nano emulsified CBN (cannabidiol). Similar to CBD, the benefits of CBN include anti-inflammatory, pain relief and enhanced sleep quality. These drops will be in 100mg and 200mg dosages which can be added sublingually or in any choice of beverage. The CBN drops are completely water-soluble that contribute to the increasing bioavailability and effects. Approximately 30% to 48% of older adults suffer from insomnia. The cumulative long-term effects of sleep disorders have been found to cause increased risks of depression, hypertension, obesity, diabetes, heart attack, and stroke. Sipp Industries plans to market Nano Drops worldwide through both online sales and traditional distribution channels.
お知らせ • Jan 05Sipp Industries, Inc. (OTCPK:SIPC) acquired 5% stake in Calypso Extracts.Sipp Industries, Inc. (OTCPK:SIPC) acquired 5% stake in Calypso Extracts on January 4, 2022. Under the terms of the agreement, Sipp Industries had acquired a 5% stake in Calypso, with an option to acquire up to 10% within 12 months. Sipp Industries, Inc. (OTCPK:SIPC) completed the acquisition of 5% stake in Calypso Extracts on January 4, 2022.
お知らせ • Aug 21Sipp Industries, Inc. Announces Appointment of Nick Pelletiere as Acting Chief Executive OfficerSipp Industries, Inc. announced appointment of Nick Pelletiere as its new Acting Chief Executive Officer. Mr. Pelletiere offers a history of profitable business ventures. He has a proven track record in driving the rapid growth and development of small and medium-sized businesses, as well as large corporations, resulting in significant increases in revenue and market share. He offers dynamic and results-driven sales with 25+ years of sales experience across various industries, marketing, and management experience as well as ownership in business partnerships. Mr. Pelletiere has a very entrepreneurial, enthusiastic, and passionate mindset to generate leads, pursue and secure new business opportunities, as well as meet and exceed sales targets.
お知らせ • Jun 25Sipp Industries, Inc. Announces Chief Executive Officer ChangesSIPP Industries, Inc. announced the appointment of Adam Graziano as the new Chief Executive Officer, effective immediately. Jakob Jorgensen, the former CEO of SIPP Industries, will remain a business consultant while also joining Calypso Pharmaceuticals as their new CEO. Mr. Jorgensen's new role will focus on advancing the recent research and development agreement between Calypso Pharmaceuticals and SIPP Industries. This collaboration aims to develop a groundbreaking topical treatment utilizing Peptide P16, designed to penetrate and destroy melanoma cells. Additionally, the partnership will explore the potential of other peptides in combating obesity, anxiety, Alzheimer’s disease, and various other conditions. Adam Graziano brings a wealth of experience and leadership to SIPP Industries. With 20 years in various business leadership roles and over 33 years in the insurance sector, while currently managing a $500 million portfolio, Mr. Graziano has consistently demonstrated his ability to guide teams in achieving and surpassing growth and financial objectives. He holds a Bachelor of Arts in Political Science with a minor in Criminal Justice from St. Cloud State University.
お知らせ • Jun 16Sipp Industries Announces Newly Released Delta-8 Sauces, Tea, Fruit Punch and Medicinal Pain LotionSipp Industries, Inc. announced that it has developed and manufactured a new line of Delta-8 (“D8”) infused sauces under the “Sauz” brand. The Company recently completed its first production run of Major Hemp D8 Sweet Lemon Tea and Fruit Punch which will be placed in retail coolers throughout the south-central states with national distribution plans underway at additional distributors. Sipp Industries also reports it officially fulfilled its first orders for the newly developed THC-infused pain lotion under the Aveina brand. With Aveina being the first THC product launch it will exclusively be sold in dispensaries throughout the state of Oklahoma. In April, Sipp Industries began the development and manufacturing process for its new line of Sauz D8 infused sauces. Inspired from an inquiry with a large prospect, Sipp Industries developed a variety of D8 nano-infused sauce flavors including BBQ, Chipotle, Siracha, Buffalo and Steak. These new 10oz sauces pack a powerful punch with 1,000mg of nano emulsified D8 providing an uplifting and euphoric eating experience with your favorite foods. Sipp Industries is planning sampling events at BBQ competitions/cook-offs and other “canna-competitions” for edibles and beverages throughout the summer. The Company is also pursuing brand ambassadors to penetrate the cannabis-infused cuisine market which has become extremely popular for celebrity chefs on Netflix shows such as Bong Appetite and Cooking on High.
お知らせ • May 06Sipp Industries Introduces New THC Nano-Infused Medicinal Body LotionSipp Industries, Inc. received an order for its newly developed THC Nano-Infused Body Lotion which will be branded and marketed under the Aveina brand. Over the past several weeks, Sipp Industries formulated and developed its first THC product which is a medicinal grade body lotion used for pain relief, anti-inflammatory, anti-aging, and anti-cancer applications. Aveina is expected to be on the shelves by the end of the month at legally operated medical marijuana dispensaries throughout the state of Oklahoma. Sipp Industries has partnered with its exclusive distributor, Argent Cannabis. Aveina will be sold in 4 oz sizes containing a potent 500mg of Nano THC. With 95% THC bioavailability, Aveina provides fast acting, effective pain relief.
お知らせ • Feb 04Sipp Industries Announces First Product Launch of 2022Sipp Industries, Inc. announced the launch of its first product of the year, Nano CBN Drops, addressing the growing cannabis sleep aid market. Sipp Industries has finalized its formula with the primary ingredient being high-grade nano emulsified CBN (cannabidiol). Similar to CBD, the benefits of CBN include anti-inflammatory, pain relief and enhanced sleep quality. These drops will be in 100mg and 200mg dosages which can be added sublingually or in any choice of beverage. The CBN drops are completely water-soluble that contribute to the increasing bioavailability and effects. Approximately 30% to 48% of older adults suffer from insomnia. The cumulative long-term effects of sleep disorders have been found to cause increased risks of depression, hypertension, obesity, diabetes, heart attack, and stroke. Sipp Industries plans to market Nano Drops worldwide through both online sales and traditional distribution channels.
お知らせ • Jan 05Sipp Industries, Inc. (OTCPK:SIPC) acquired 5% stake in Calypso Extracts.Sipp Industries, Inc. (OTCPK:SIPC) acquired 5% stake in Calypso Extracts on January 4, 2022. Under the terms of the agreement, Sipp Industries had acquired a 5% stake in Calypso, with an option to acquire up to 10% within 12 months. Sipp Industries, Inc. (OTCPK:SIPC) completed the acquisition of 5% stake in Calypso Extracts on January 4, 2022.
お知らせ • Aug 21Sipp Industries, Inc. Announces Appointment of Nick Pelletiere as Acting Chief Executive OfficerSipp Industries, Inc. announced appointment of Nick Pelletiere as its new Acting Chief Executive Officer. Mr. Pelletiere offers a history of profitable business ventures. He has a proven track record in driving the rapid growth and development of small and medium-sized businesses, as well as large corporations, resulting in significant increases in revenue and market share. He offers dynamic and results-driven sales with 25+ years of sales experience across various industries, marketing, and management experience as well as ownership in business partnerships. Mr. Pelletiere has a very entrepreneurial, enthusiastic, and passionate mindset to generate leads, pursue and secure new business opportunities, as well as meet and exceed sales targets.
